About CME in Minutes: Education in Oncology & Hematology
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Oncology & Hematology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for oncologists and hematologists to cover the diagnosis, staging, treatment, follow-up, and clinical management of tumors and hematological malignancies. Earning your CME/CE credits has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.
CELMoDs in Action: Integrating New Clinical Evidence Into Real-World RRMM Management
Please visit answersincme.com/860/104092969-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Beth Faiman, PhD, MSN, APN-BC, TCTCN, AOCN, FAAN, FAPO; and Jesus Berdeja, MD. In this activity, experts in hematology-oncology discuss the evolving role of cereblon E3 ligase modulators (CELMoDs) in patients with relapsed/refractory multiple myeloma (RRMM). Upon completion of this activity, participants should be better able to: Identify the role of CELMoDs in the treatment of patients with RRMM. Utilize evidence-based practical strategies for the management of key adverse events associated with CELMoDs in patients with RRMM. Apply key considerations to support the integration of CELMoDs into the treatment paradigm for patients with RRMM.
20 Oct 2026
Mastering Anti-CD38 Therapy in Multiple Myeloma Care: Case-Based Education for Advanced Practitioners and Oncology Nurses
Please visit answersincme.com/860/2026-MC-002375-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Beth Faiman, PhD, MSN, APN-BC, TCTCN, AOCN, FAAN, FAPO; and Krina Patel, MD, MSc. In this activity, experts in multiple myeloma discuss key treatment considerations and personalization strategies for anti-CD38 therapy. Upon completion of this activity, participants should be better able to: Evaluate the clinical implications of key data supporting anti-CD38–based regimens in patients with multiple myeloma (MM); Outline evidence-based strategies to manage toxicities associated with anti-CD38–based therapies; Identify key considerations for integrating anti-CD38 monoclonal antibodies into treatment plans for patients with MM; and Apply practical, patient-centered care considerations to optimize outcomes with anti-CD38 monoclonal antibodies for patients with MM.
9 Oct 2026
Unlocking New Horizons: Preparing for the CLDN18.2-Targeting ADCs in Advanced Gastric/GEJ Cancer
Please visit answersincme.com/CJF860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Manuel Rodriguez-Justo, MBBCh, MSc, MD, FRCPath; and Elizabeth Smyth, MD, FRCP. In this activity, experts in oncology and pathology discuss the impact of claudin 18.2 (CLDN18.2) tests and treatments for patients with advanced gastric or gastroesophageal junction cancers. Upon completion of this activity, participants should be better able to: Describe the rationale for CLDN18.2 testing in patients with advanced gastric and gastroesophageal junction cancers (GC/GEJC); Review the potential clinical impact of emerging CLDN18.2-targeted antibody-drug conjugates (ADCs) for the treatment of GC/GEJC; and Outline evidence-based, emerging strategies to optimize outcomes in patients with advanced GC/GEJC.
Who has been a guest on CME in Minutes: Education in Oncology & Hematology
Names identified in recent episode analyses. Showing up to five guests.
Hussein Tawbi MD PhD
Selim Corbacioglu
Thomas Powles
Jonathan E Rosenberg
Barbara Burtness MD
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
8 ratings
Spotify
5.0 / 5
2 ratings
Podcast Authority Score: 36 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
45
Social presence
0
YouTube
0
Engagement
68
Contact CME in Minutes: Education in Oncology & Hematology
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
